Morse Asset Management, Inc Amarin Corp Plcuk Transaction History

Morse Asset Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $485,528 - $839,009	-101,575 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$4.0 - $21.53 $16,500 - $88,811	4,125 Added 4.23%	101,575 $406,000
Q4 2019 Jan 31, 2020	SELL	$13.94 - $24.12 $4,739 - $8,200	-340 Reduced 0.35%	97,450 $2.09 Million
Q3 2019 Nov 05, 2019	BUY	$13.89 - $23.16 $807,564 - $1.35 Million	58,140 Added 146.63%	97,790 $1.48 Million
Q2 2019 Aug 01, 2019	BUY	$16.27 - $20.51 $645,105 - $813,221	39,650 New	39,650 $769,000

187

77.1M

247K

121K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $250M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Morse Asset Management, Inc with notifications on news.